Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 3 3Phase 2/3 2Phase 2 2

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 27Neoplasm Metastasis 3Prostate Cancer Metastatic 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Metastatic Hormone-sensitive Prostate Cancer 2Prostatic Neoplasms, Castration-Resistant 1Prostatic Diseases 1Neoplasms 1Metastatic Hormone Sensitive Prostate Cancer 1Metastatic Castrate-sensitive Prostate Cancer 1Genital Diseases, Male 1Abiraterone Acetate 1

Interventions

Leucovorin 22Fluorouracil 22Paclitaxel 21Gemcitabine 21Docetaxel 21Capecitabine 21Irinotecan 16Carboplatin 15Radiosurgery 14Oxaliplatin 13Cisplatin 13Bevacizumab 13Zoledronic Acid 12pembrolizumab 11Radiotherapy 11Fulvestrant 11palbociclib 9Pemetrexed 9Drug Therapy 9130-nm albumin-bound paclitaxel 9Surgical Procedures, Operative 7Letrozole 7Ibandronic Acid 7abemaciclib 6Trastuzumab 6Prednisone 6Vinorelbine 5Folfox protocol 5Floxuridine 5Doxorubicin 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Neoplasm Metastasis × Androgen Antagonists × Clear all
NCT05352178 2024-07-03

SPARKLE

Universitaire Ziekenhuizen KU Leuven

Phase 3 Recruiting
873 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT00079001 2020-05-12

Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases

Alliance for Clinical Trials in Oncology

Phase 3 Completed
645 enrolled 13 charts
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT00685646 2015-10-16

ZAPCA

Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

Phase 3 Completed
227 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡